Research Projects & Grants

For Profit Organization

• The effect of milnacipran on fatigue and quality of life in a lupus cohort, Role: PI, Forest Laboratories, Inc., (01/2014 - 01/2015) Status: Completed
• A golimumab phase 3b, multicenter, switch assessment of subcutaneous and intravenous efficacy in rheumatoid arthritis patients who have inadequate disease control despite treatment with etanercept (ENBREL®) or adalimumab (HUMIRA®), Role: Investigator, Centocor, Inc., (10/2013 - 10/2014) Status: Completed
• A phase 1, randomized, double-blind, placebo-controlled study of the safety and tolerability of MEDI-551 in scleroderma, Role: PI, MedImmune, Inc., (12/2012 - 12/2013) Status: Completed
• Protocol RA0064: A phase 4, multicenter, randomized, 52-week study to evaluate the routine assessment of patient index data (RAPID3) compared to the clinical disease activity index (CDAI) to prospectively predict treament success at 52 weeks based on a treatment decision at week 12 in subjects with moderate to severe rheumatoid arthritis receiving Certolizumab Pegol (CZP), Role: PI, UCB Biosciences Inc., (07/2012 - 07/2013) Status: Completed

Internal

• The effect of ant-TNF-a therapy on bone mineral density in rheumatoid arthritis patients, Role: PI, LLU Dept. of Medicine, (12/2011 - 12/2012) Status: Completed
• Cross cultural Spanish validation of LupusPRO: A patient reported outcome measure of lupus, Role: PI, LLU Dept. of Medicine, (08/2010 - 08/2011) Status: Completed
• An exploration of the psychosocial correlates of fibromyalgia syndrome and rheumatoid arthritis, Role: Investigator, LLU Dept. of Psychology, (08/2005 - 08/2006) Status: Completed

Other Research

• Psychosocial Predictors of Fibromyalgia: A comparison with Rheumatoid Arthritis Patients. (03/2006 - 12/2012)
• An Exploration of the Psychosocial Correlates of Fibromyalgia Syndrome and Rheumatoid Arthritis (09/2005 - 12/2012)